The Summary
In a randomized controlled trial, researchers examined 60 patients aged 55 to 85 with early-to-mid-stage Alzheimer’s disease over six months. Participants received either standard medical care alone or standard care combined with an individualized plant-rich ketogenic diet and intermittent fasting. Cognitive performance was evaluated using the Mini-Mental State Examination (MMSE). While the control group experienced an average decline of 1.5 points, the dietary intervention group improved by 0.9 points. Overall, 93% of the dietary intervention group maintained cognitive stability compared to 70% of controls, highlighting significant therapeutic potential.
Why this is interesting
Alzheimer's disease has long been viewed as an inevitable, irreversible decline with limited pharmaceutical solutions. This study challenges that outlook by showing that metabolic interventions can actively stabilize mental function. By shifting the brain's energy supply via fasting and ketone production from plant-forward foods, patients preserved cognitive abilities that normally deteriorate. For patients and caregivers, this provides compelling evidence that personalized nutritional strategies can act as powerful, accessible complements to standard medical therapies, potentially altering the trajectory of early-stage neurodegenerative disease.